Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 NR5A2 HDX ZNF534 ZNF431 RORA ZNF701 ZNF679 PRDM2	1.74e-04	1412	66	14	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 NR5A2 HDX ZNF534 ZNF431 RORA ZNF701 ZNF679	1.85e-04	1244	66	13	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 NR5A2 HDX ZNF534 ZNF431 RORA ZNF701 ZNF679	2.28e-04	1271	66	13	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 NR5A2 HDX ZNF534 ZNF431 RORA ZNF701 ZNF679 PRDM2	2.45e-04	1459	66	14	GO:0000977
GeneOntologyMolecularFunction	structural constituent of skin epidermis	KRT81 KRT83 KRT86	3.87e-04	43	66	3	GO:0030280
GeneOntologyMolecularFunction	proteoglycan binding	THBS1 PTPRC LRP1	6.41e-04	51	66	3	GO:0043394
GeneOntologyBiologicalProcess	transforming growth factor beta receptor signaling pathway	THBS1 FBN2 ZFYVE9 LRP1 LTBP1 ADAM17 PML	2.55e-05	276	65	7	GO:0007179
GeneOntologyBiologicalProcess	regulation of transforming growth factor beta receptor signaling pathway	THBS1 FBN2 ZFYVE9 LRP1 LTBP1 ADAM17	3.15e-05	192	65	6	GO:0017015
GeneOntologyBiologicalProcess	regulation of cellular response to transforming growth factor beta stimulus	THBS1 FBN2 ZFYVE9 LRP1 LTBP1 ADAM17	3.44e-05	195	65	6	GO:1903844
GeneOntologyBiologicalProcess	sequestering of TGFbeta in extracellular matrix	FBN2 LTBP1	5.84e-05	4	65	2	GO:0035583
GeneOntologyBiologicalProcess	negative regulation of cellular component organization	LMOD3 THBS1 EFEMP1 CENPF TRPC5 MID1 LRP1 ADAM17 BECN1 TMEFF2 PML	7.38e-05	864	65	11	GO:0051129
GeneOntologyBiologicalProcess	cellular response to transforming growth factor beta stimulus	THBS1 FBN2 ZFYVE9 LRP1 LTBP1 ADAM17 PML	8.85e-05	336	65	7	GO:0071560
GeneOntologyBiologicalProcess	intermediate filament organization	KRT39 KRT81 KRT83 KRT86	9.23e-05	75	65	4	GO:0045109
GeneOntologyBiologicalProcess	response to transforming growth factor beta	THBS1 FBN2 ZFYVE9 LRP1 LTBP1 ADAM17 PML	1.01e-04	343	65	7	GO:0071559
GeneOntologyBiologicalProcess	cell surface receptor protein serine/threonine kinase signaling pathway	THBS1 FBN2 ZFYVE9 LRP1 LTBP1 ADAM17 BECN1 PML	1.32e-04	482	65	8	GO:0007178
HumanPheno	Abnormal perifollicular morphology	KRT81 KRT83 KRT86 LRP1	7.95e-09	6	26	4	HP:0031285
HumanPheno	Perifollicular hyperkeratosis	KRT81 KRT83 KRT86	4.71e-07	4	26	3	HP:0007468
HumanPheno	Abnormality of hair growth rate	KRT81 KRT83 KRT86 ADAM17	1.16e-05	29	26	4	HP:0011363
HumanPheno	Slow-growing hair	KRT81 KRT83 KRT86 ADAM17	1.16e-05	29	26	4	HP:0002217
HumanPheno	Follicular hyperkeratosis	KRT81 KRT83 KRT86 LRP1	1.34e-05	30	26	4	HP:0007502
HumanPheno	Abnormality of hair growth	KRT81 KRT83 KRT86 ADAM17	1.34e-05	30	26	4	HP:0040170
HumanPheno	Keratosis pilaris	KRT81 KRT83 KRT86 LRP1	3.14e-05	37	26	4	HP:0032152
HumanPheno	Abnormal duodenum morphology	XYLT2 FBN2 CENPF ADAM17 PALB2	6.78e-05	88	26	5	HP:0002246
HumanPheno	Choroidal neovascularization	XYLT2 FBN2 EFEMP1	1.95e-04	23	26	3	HP:0011506
MousePheno	abnormal bone mineral content	KDM3A LMOD3 THBS1 FBN2 THSD7A ZNF665 ZNF347 SCAF11 BICRAL LTBP1 ADAM17 TG	1.09e-05	713	53	12	MP:0010122
Domain	EGF-like_CS	THBS1 FBN2 EFEMP1 ATRNL1 LRP1 LTBP1 ADAM17 C8A LRP1B TMEFF2	1.59e-08	261	63	10	IPR013032
Domain	cEGF	FBN2 EFEMP1 LRP1 LTBP1 LRP1B	2.31e-08	26	63	5	IPR026823
Domain	cEGF	FBN2 EFEMP1 LRP1 LTBP1 LRP1B	2.31e-08	26	63	5	PF12662
Domain	EGF_3	THBS1 FBN2 EFEMP1 ATRNL1 LRP1 LTBP1 C8A LRP1B TMEFF2	8.89e-08	235	63	9	PS50026
Domain	EGF-like_dom	THBS1 FBN2 EFEMP1 ATRNL1 LRP1 LTBP1 C8A LRP1B TMEFF2	1.46e-07	249	63	9	IPR000742
Domain	EGF_1	THBS1 FBN2 EFEMP1 ATRNL1 LRP1 LTBP1 C8A LRP1B TMEFF2	1.78e-07	255	63	9	PS00022
Domain	EGF_2	THBS1 FBN2 EFEMP1 ATRNL1 LRP1 LTBP1 C8A LRP1B TMEFF2	2.47e-07	265	63	9	PS01186
Domain	EGF_CA	THBS1 FBN2 EFEMP1 LRP1 LTBP1 LRP1B	4.40e-07	86	63	6	PF07645
Domain	Growth_fac_rcpt_	FBN2 EFEMP1 KRT83 LRP1 LTBP1 C8A LRP1B	9.26e-07	156	63	7	IPR009030
Domain	EGF	THBS1 FBN2 EFEMP1 ATRNL1 LRP1 LTBP1 LRP1B TMEFF2	1.19e-06	235	63	8	SM00181
Domain	EGF_CA	THBS1 FBN2 EFEMP1 LRP1 LTBP1 LRP1B	3.44e-06	122	63	6	SM00179
Domain	EGF-like_Ca-bd_dom	THBS1 FBN2 EFEMP1 LRP1 LTBP1 LRP1B	3.78e-06	124	63	6	IPR001881
Domain	DUF5050	LRP1 LRP1B	1.12e-05	2	63	2	IPR032485
Domain	DUF5050	LRP1 LRP1B	1.12e-05	2	63	2	PF16472
Domain	LY	LRP1 ROS1 LRP1B	1.62e-05	15	63	3	SM00135
Domain	LDLR_classB_rpt	LRP1 ROS1 LRP1B	1.62e-05	15	63	3	IPR000033
Domain	zf-C2H2	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679 PRDM2	1.80e-05	693	63	11	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679 PRDM2	1.82e-05	694	63	11	IPR013087
Domain	EGF_Ca-bd_CS	FBN2 EFEMP1 LRP1 LTBP1 LRP1B	1.89e-05	97	63	5	IPR018097
Domain	EGF_CA	FBN2 EFEMP1 LRP1 LTBP1 LRP1B	2.08e-05	99	63	5	PS01187
Domain	ASX_HYDROXYL	FBN2 EFEMP1 LRP1 LTBP1 LRP1B	2.19e-05	100	63	5	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBN2 EFEMP1 LRP1 LTBP1 LRP1B	2.90e-05	106	63	5	IPR000152
Domain	ZINC_FINGER_C2H2_2	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679 PRDM2	5.01e-05	775	63	11	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679 PRDM2	5.13e-05	777	63	11	PS00028
Domain	Intermediate_filament_CS	KRT39 KRT81 KRT83 KRT86	6.03e-05	63	63	4	IPR018039
Domain	Znf_C2H2-like	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679 PRDM2	6.37e-05	796	63	11	IPR015880
Domain	Keratin_2_head	KRT81 KRT83 KRT86	7.04e-05	24	63	3	IPR032444
Domain	Keratin_2_head	KRT81 KRT83 KRT86	7.04e-05	24	63	3	PF16208
Domain	Znf_C2H2	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679 PRDM2	7.05e-05	805	63	11	IPR007087
Domain	ZnF_C2H2	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679 PRDM2	7.29e-05	808	63	11	SM00355
Domain	-	ZNF600 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679 PRDM2	8.45e-05	679	63	10	3.30.160.60
Domain	Keratin_II	KRT81 KRT83 KRT86	9.00e-05	26	63	3	IPR003054
Domain	Filament	KRT39 KRT81 KRT83 KRT86	9.64e-05	71	63	4	SM01391
Domain	IF	KRT39 KRT81 KRT83 KRT86	1.02e-04	72	63	4	PS00226
Domain	Filament	KRT39 KRT81 KRT83 KRT86	1.07e-04	73	63	4	PF00038
Domain	IF	KRT39 KRT81 KRT83 KRT86	1.26e-04	76	63	4	IPR001664
Domain	KRAB	ZNF713 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679	1.97e-04	358	63	7	PS50805
Domain	KRAB	ZNF713 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679	1.97e-04	358	63	7	PF01352
Domain	TB	FBN2 LTBP1	2.33e-04	7	63	2	PF00683
Domain	KRAB	ZNF713 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679	2.37e-04	369	63	7	SM00349
Domain	KRAB	ZNF713 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679	2.41e-04	370	63	7	IPR001909
Domain	-	LRP1 ROS1 LRP1B	3.07e-04	39	63	3	2.120.10.30
Domain	-	FBN2 LTBP1	3.09e-04	8	63	2	3.90.290.10
Domain	LDLR_class-A_CS	LRP1 C8A LRP1B	3.31e-04	40	63	3	IPR023415
Domain	TB	FBN2 LTBP1	3.97e-04	9	63	2	PS51364
Domain	TB_dom	FBN2 LTBP1	3.97e-04	9	63	2	IPR017878
Domain	Ldl_recept_a	LRP1 C8A LRP1B	4.69e-04	45	63	3	PF00057
Domain	-	LRP1 C8A LRP1B	5.01e-04	46	63	3	4.10.400.10
Domain	6-blade_b-propeller_TolB-like	LRP1 ROS1 LRP1B	5.01e-04	46	63	3	IPR011042
Domain	LDLRA_1	LRP1 C8A LRP1B	5.68e-04	48	63	3	PS01209
Domain	LDLRA_2	LRP1 C8A LRP1B	6.03e-04	49	63	3	PS50068
Domain	LDrepeatLR_classA_rpt	LRP1 C8A LRP1B	6.03e-04	49	63	3	IPR002172
Domain	LDLa	LRP1 C8A LRP1B	6.03e-04	49	63	3	SM00192
Domain	zf-C2H2_6	ZNF600 ZNF652 ZNF790 ZNF431 ZNF701 PRDM2	6.54e-04	314	63	6	PF13912
Domain	EGF	LRP1 LTBP1 LRP1B TMEFF2	8.65e-04	126	63	4	PF00008
Domain	Ldl_recept_b	LRP1 LRP1B	9.93e-04	14	63	2	PF00058
Domain	LDLRB	LRP1 LRP1B	9.93e-04	14	63	2	PS51120
Domain	TSP_1	THBS1 THSD7A C8A	1.26e-03	63	63	3	PF00090
Domain	TSP1	THBS1 THSD7A C8A	1.38e-03	65	63	3	SM00209
Domain	TSP1_rpt	THBS1 THSD7A C8A	1.38e-03	65	63	3	IPR000884
Domain	TSP1	THBS1 THSD7A C8A	1.38e-03	65	63	3	PS50092
Domain	Znf_FYVE_PHD	KDM3A ZFYVE9 PHF3 BSN	1.53e-03	147	63	4	IPR011011
Domain	-	ZFYVE9 PHF3 MID1 SCAF11 BSN PML	3.99e-03	449	63	6	3.30.40.10
Domain	Znf_RING/FYVE/PHD	ZFYVE9 PHF3 MID1 SCAF11 BSN PML	4.44e-03	459	63	6	IPR013083
Pubmed	Structure and site of expression of a murine type II hair keratin.	KRT81 KRT83 KRT86	6.83e-09	3	67	3	1372089
Pubmed	Transient expression of mouse hair keratins in transfected HeLa cells: interactions between "hard" and "soft" keratins.	KRT81 KRT83 KRT86	6.83e-09	3	67	3	1712823
Pubmed	Novel KRT83 and KRT86 mutations associated with monilethrix.	KRT81 KRT83 KRT86	6.83e-09	3	67	3	25557232
Pubmed	Comprehensive analysis of keratin gene clusters in humans and rodents.	KRT39 KRT81 KRT83 KRT86	2.25e-08	16	67	4	15085952
Pubmed	Keratins of the human hair follicle.	KRT81 KRT83 KRT86	2.73e-08	4	67	3	15797458
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	THBS1 FBN2 THSD7A ATRNL1 LRP1	2.69e-07	71	67	5	33541421
Pubmed	Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain.	KRT81 KRT83 KRT86	1.48e-06	12	67	3	10692104
Pubmed	Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages.	LRP1 ADAM17	3.66e-06	2	67	2	20610799
Pubmed	Striking differences of LDL receptor-related protein 1B expression in mouse and human.	LRP1 LRP1B	3.66e-06	2	67	2	15963947
Pubmed	Ceramide kinase regulates the production of tumor necrosis factor α (TNFα) via inhibition of TNFα-converting enzyme.	CERK ADAM17	3.66e-06	2	67	2	22009748
Pubmed	A missense mutation in the type II hair keratin hHb3 is associated with monilethrix.	KRT83 KRT86	3.66e-06	2	67	2	15744029
Pubmed	Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans.	THBS1 LRP1	3.66e-06	2	67	2	14991768
Pubmed	Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17.	ADAM17 TMEFF2	3.66e-06	2	67	2	17942404
Pubmed	Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.	THBS1 LRP1	3.66e-06	2	67	2	25393517
Pubmed	HPP1 Ectodomain Shedding is Mediated by ADAM17 and is Necessary for Tumor Suppression in Colon Cancer.	ADAM17 TMEFF2	3.66e-06	2	67	2	32450419
Pubmed	A variable monilethrix phenotype associated with a novel mutation, Glu402Lys, in the helix termination motif of the type II hair keratin hHb1.	KRT81 KRT86	3.66e-06	2	67	2	9665406
Pubmed	Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein.	THBS1 LRP1	3.66e-06	2	67	2	9045712
Pubmed	Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).	THBS1 LRP1	3.66e-06	2	67	2	17154366
Pubmed	A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix.	KRT81 KRT86	3.66e-06	2	67	2	9402962
Pubmed	Regulation of T-lymphocyte motility, adhesion and de-adhesion by a cell surface mechanism directed by low density lipoprotein receptor-related protein 1 and endogenous thrombospondin-1.	THBS1 LRP1	3.66e-06	2	67	2	24877199
Pubmed	PERP regulates enamel formation via effects on cell-cell adhesion and gene expression.	KRT81 KRT83 KRT86	6.48e-06	19	67	3	21285247
Pubmed	New consensus nomenclature for mammalian keratins.	KRT39 KRT81 KRT83 KRT86	6.88e-06	63	67	4	16831889
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 KDM3A CERK FBXL7 VPS13C SLMAP SCAF11 BSN	8.07e-06	529	67	8	14621295
Pubmed	HTRA1, an age-related macular degeneration protease, processes extracellular matrix proteins EFEMP1 and TSP1.	THBS1 EFEMP1	1.10e-05	3	67	2	29730901
Pubmed	Sequence data and chromosomal localization of human type I and type II hair keratin genes.	KRT81 KRT86	1.10e-05	3	67	2	7556444
Pubmed	Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis.	THBS1 LRP1	1.10e-05	3	67	2	18653767
Pubmed	Sequences and differential expression of three novel human type-II hair keratins.	KRT83 KRT86	1.10e-05	3	67	2	9084137
Pubmed	Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.	BECN1 PALB2	1.10e-05	3	67	2	23650262
Pubmed	Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17.	LYPD3 ADAM17	1.10e-05	3	67	2	18979631
Pubmed	Decorin-inducible Peg3 Evokes Beclin 1-mediated Autophagy and Thrombospondin 1-mediated Angiostasis.	THBS1 BECN1	1.10e-05	3	67	2	28174297
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 CENPF LRP1 AKAP1 MBIP PALB2 PRDM2	1.61e-05	418	67	7	34709266
Pubmed	Interaction between the C8 alpha-gamma and C8 beta subunits of human complement C8: role of the C8 beta N-terminal thrombospondin type 1 module and membrane attack complex/perforin domain.	THBS1 C8A	2.19e-05	4	67	2	12220191
Pubmed	Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.	FBN2 LTBP1	2.19e-05	4	67	2	12429738
Pubmed	A Disintegrin and Metalloproteinase 17 is required for ILC2 responses to IL-33.	RORA ADAM17	2.19e-05	4	67	2	30926166
Pubmed	Human eye development is characterized by coordinated expression of fibrillin isoforms.	FBN2 EFEMP1	2.19e-05	4	67	2	25406291
Pubmed	Functions for Retinoic Acid-Related Orphan Receptor Alpha (RORα) in the Activation of Macrophages During Lipopolysaccharide-Induced Septic Shock.	PTPRC RORA	2.19e-05	4	67	2	33767712
Pubmed	Characterization and chromosomal localization of human hair-specific keratin genes and comparative expression during the hair growth cycle.	KRT81 KRT86	2.19e-05	4	67	2	9457912
Pubmed	Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1.	THBS1 LRP1	2.19e-05	4	67	2	7775583
Pubmed	Retinoic Acid-Related Orphan Receptor α Is Required for Generation of Th2 Cells in Type 2 Pulmonary Inflammation.	PTPRC RORA	3.64e-05	5	67	2	37387671
Pubmed	Autophagy controls mucus secretion from intestinal goblet cells by alleviating ER stress.	BECN1 NOD2	3.64e-05	5	67	2	36738733
Pubmed	POGLUT2 and POGLUT3 O-glucosylate multiple EGF repeats in fibrillin-1, -2, and LTBP1 and promote secretion of fibrillin-1.	FBN2 LTBP1	3.64e-05	5	67	2	34411563
Pubmed	Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells.	PTPRC BECN1	3.64e-05	5	67	2	38754428
Pubmed	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	TET2 EFEMP1 ZNF652 LTBP1 PML	4.12e-05	198	67	5	20881960
Pubmed	Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.	FBN2 TMEFF2	5.46e-05	6	67	2	19288010
Pubmed	High-throughput mammalian two-hybrid screening for protein-protein interactions using transfected cell arrays.	THBS1 FBN2	5.46e-05	6	67	2	18254948
Pubmed	An extended consensus motif enhances the specificity of substrate modification by SUMO.	NR5A2 PML	5.46e-05	6	67	2	17036045
Pubmed	Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.	BSN NOD2	5.46e-05	6	67	2	20024904
Pubmed	Cytoplasmic PML function in TGF-beta signalling.	ZFYVE9 PML	5.46e-05	6	67	2	15356634
Pubmed	TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.	RORA PML	5.46e-05	6	67	2	28486108
Pubmed	Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.	THBS1 LTBP1	7.63e-05	7	67	2	19998449
Pubmed	Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling.	ZFYVE9 PML	7.63e-05	7	67	2	16916642
Pubmed	Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling.	ZFYVE9 PML	1.02e-04	8	67	2	18511908
Pubmed	Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL).	THBS1 FBN2 EFEMP1 KRT81 LTBP1	1.17e-04	247	67	5	39238192
Pubmed	Selective autophagy of RIPosomes maintains innate immune homeostasis during bacterial infection.	BECN1 NOD2	1.30e-04	9	67	2	36221902
Pubmed	Poglut2/3 double knockout in mice results in neonatal lethality with reduced levels of fibrillin in lung tissues.	FBN2 LTBP1	1.30e-04	9	67	2	38844137
Pubmed	TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation.	MID1 NOD2	1.30e-04	9	67	2	22829933
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF665 ZNF790 ZNF347 NR5A2 ZDHHC14 RORA ZNF679 PML	1.60e-04	808	67	8	20412781
Pubmed	Maturation of the HIV reverse transcription complex: putting the jigsaw together.	AKAP1 PML	1.63e-04	10	67	2	19750561
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 KDM3A THBS1 EFEMP1 ATRNL1 KRT83 LRP1 SESN3 BECN1 LRP1B	1.67e-04	1285	67	10	35914814
Pubmed	Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.	BSN PALB2 NOD2	1.95e-04	58	67	3	17554300
Pubmed	Genomic organization, nucleotide sequence, biophysical properties, and localization of the voltage-gated K+ channel gene KCNA4/Kv1.4 to mouse chromosome 2/human 11p14 and mapping of KCNC1/Kv3.1 to mouse 7/human 11p14.3-p15.2 and KCNA1/Kv1.1 to human 12p13.	THBS1 KCNA1	1.99e-04	11	67	2	8020965
Pubmed	LRP2 mediates folate uptake in the developing neural tube.	LRP1 LRP1B	1.99e-04	11	67	2	24639464
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	KRT81 KRT83 KRT86 LTBP1 PRDM2	2.24e-04	284	67	5	29459677
Pubmed	Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models.	PTPRC TG	2.81e-04	13	67	2	22724066
Pubmed	IRGM governs the core autophagy machinery to conduct antimicrobial defense.	BECN1 NOD2	2.81e-04	13	67	2	25891078
Pubmed	Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1.	LRP1 LRP1B	3.28e-04	14	67	2	15082773
Pubmed	DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis.	KRT81 KRT83 KRT86	3.41e-04	70	67	3	34255829
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	THBS1 FBN2 EFEMP1 LTBP1	3.71e-04	175	67	4	28071719
Pubmed	Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit.	NR5A2 RORA	3.78e-04	15	67	2	14701856
Pubmed	TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression.	TET2 KDM3A	3.78e-04	15	67	2	31530896
Pubmed	Hague (Hag). A new mouse hair mutation with an unstable semidominant allele.	KRT81 KRT86	4.31e-04	16	67	2	12399393
Pubmed	Esophageal Atresia / Tracheoesophageal Fistula Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	MID1 PALB2	4.31e-04	16	67	2	20301753
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	XYLT2 THBS1 FBN2 EFEMP1 LRP1 LTBP1 ADAM17 AKAP1 LRP1B	4.79e-04	1201	67	9	35696571
Pubmed	A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales.	FBN2 TG	4.88e-04	17	67	2	22832960
Pubmed	The expression pattern of nuclear receptors during cerebellar development.	NR5A2 RORA	4.88e-04	17	67	2	17205580
Pubmed	Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.	PTPRC ADAM17	4.88e-04	17	67	2	17804806
Pubmed	Deletion of the epidermis derived laminin γ1 chain leads to defects in the regulation of late hair morphogenesis.	KRT81 KRT86	6.12e-04	19	67	2	27234308
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	THBS1 FBN2 LTBP1	6.24e-04	86	67	3	28327460
Pubmed	Association of linear growth impairment in pediatric Crohn's disease and a known height locus: a pilot study.	EFEMP1 BSN	6.79e-04	20	67	2	20846217
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	PHF3 MID1 BSN PRDM2	7.10e-04	208	67	4	33230847
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KDM3A PTPRC PHF3 SCAF11 AKAP1 PALB2 PRDM2	7.19e-04	774	67	7	15302935
Pubmed	MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm.	LRP1 LRP1B	7.50e-04	21	67	2	21337463
Pubmed	Hippo signaling regulates differentiation and maintenance in the exocrine pancreas.	PTPRC NR5A2	8.24e-04	22	67	2	23454691
Pubmed	A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors.	NR5A2 RORA	8.24e-04	22	67	2	23975195
Pubmed	Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy.	KRT81 KRT83 KRT86	8.59e-04	96	67	3	23580065
Pubmed	Functional proteomics mapping of a human signaling pathway.	FBN2 PTPRC ZFYVE9 THSD7A KRT81 LRP1	9.74e-04	591	67	6	15231748
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	LRP1 GABRQ LRP1B	9.95e-04	101	67	3	23382219
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	THBS1 EFEMP1 LTBP1	9.95e-04	101	67	3	20551380
Pubmed	ERp57 is essential for efficient folding of glycoproteins sharing common structural domains.	EFEMP1 ADAM17	1.07e-03	25	67	2	17170699
Pubmed	Identification of 15 loci influencing height in a Korean population.	EFEMP1 LTBP1	1.24e-03	27	67	2	19893584
Pubmed	Identification of differentially expressed genes in mouse spermatogenesis.	ZNF665 ZNF347	1.24e-03	27	67	2	14581517
Pubmed	Genetic risk profiling and prediction of disease course in Crohn's disease patients.	BSN NOD2	1.34e-03	28	67	2	19422935
Pubmed	Alternatively spliced isoforms of WT1 control podocyte-specific gene expression.	SGIP1 THSD7A	1.34e-03	28	67	2	25993318
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	THBS1 EFEMP1 LTBP1 ADAM17	1.36e-03	248	67	4	24006456
Pubmed	ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1.	FBN2 ANKRD26 BSN	1.38e-03	113	67	3	34474245
Pubmed	Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function.	TET2 LRP1	1.54e-03	30	67	2	21946350
Pubmed	ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation.	FBN2 LTBP1	1.54e-03	30	67	2	32882513
Pubmed	Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.	EFEMP1 LRP1 LTBP1	1.56e-03	118	67	3	21078624
Pubmed	Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia.	FBN2 LTBP1	1.64e-03	31	67	2	25762570
Pubmed	Molecular and spatial landmarks of early mouse skin development.	THBS1 PTPRC	1.86e-03	33	67	2	37591247
Interaction	ZFP41 interactions	FBN2 LRP1 LTBP1 AKAP1 LRP1B	1.19e-06	57	66	5	int:ZFP41
Interaction	ZDHHC15 interactions	THBS1 FBN2 THSD7A ATRNL1 LRP1 TMEFF2	3.38e-06	125	66	6	int:ZDHHC15
Cytoband	12q13	KRT81 KRT83 KRT86	1.58e-04	71	67	3	12q13
Cytoband	19q13.41	ZNF600 ZNF534 ZNF701	2.09e-04	78	67	3	19q13.41
Cytoband	15q22.2	VPS13C RORA	8.30e-04	29	67	2	15q22.2
Cytoband	Ensembl 112 genes in cytogenetic band chr3p14	LMOD3 CCDC66 SLMAP	1.15e-03	140	67	3	chr3p14
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF600 ZNF665 ZNF790 ZNF347 LYPD3 ZNF534 ZNF701	1.75e-03	1192	67	7	chr19q13
Cytoband	Ensembl 112 genes in cytogenetic band chr12q13	KRT81 KRT83 KRT86 LRP1	3.45e-03	423	67	4	chr12q13
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF600 ZNF713 ZNF665 ZNF652 ZNF790 ZNF347 ZNF534 ZNF431 ZNF701 ZNF679	1.85e-05	718	49	10	28
GeneFamily	Keratins, type II	KRT81 KRT83 KRT86	5.23e-05	27	49	3	609
GeneFamily	Low density lipoprotein receptors	LRP1 LRP1B	5.51e-04	13	49	2	634
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	FBN2 EFEMP1 ATRNL1 LRP1 LTBP1 TMEFF2	4.08e-05	207	65	6	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500	KDM3A FBN2 EFEMP1 ATRNL1 LRP1 SESN3 LTBP1 TMEFF2	4.34e-05	423	65	8	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	FBXL7 SGIP1 THSD7A NR5A2 ZDHHC14 TM4SF18	2.43e-07	173	67	6	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	THBS1 EFEMP1 FBXL7 SGIP1 MID1 TM4SF18	2.52e-07	174	67	6	d551bc29afef071adf4c9bb80345352ec33441d8
ToppCell	COVID-19-Neuronal_cells-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	FBXL7 SGIP1 THSD7A NR5A2 ZDHHC14 TM4SF18	3.61e-07	185	67	6	4a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCell	COVID-19-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	FBXL7 SGIP1 THSD7A NR5A2 ZDHHC14 TM4SF18	3.61e-07	185	67	6	36ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBXL7 SGIP1 THSD7A NR5A2 ZDHHC14 TM4SF18	3.97e-07	188	67	6	2db80767903703e7e0a1a37c598f7877a909ee94
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	4.92e-07	195	67	6	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	4.92e-07	195	67	6	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THBS1 SGIP1 VPS13C LRP1 RORA SCAF11	4.92e-07	195	67	6	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FBXL7 SGIP1 THSD7A NR5A2 ZDHHC14 TM4SF18	5.37e-07	198	67	6	b3a020522e064bb61949d38e442f24026e339364
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FBXL7 SGIP1 THSD7A NR5A2 ZDHHC14 TM4SF18	5.37e-07	198	67	6	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 PTPRC PHF3 VPS13C SCAF11 PRDM2	5.70e-07	200	67	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF713 CCDC66 ANKRD26 SESN3 TG	4.19e-06	159	67	5	b9d34b9ed8db798f5ea93c44b469cae499403cb8
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	FBXL7 SGIP1 THSD7A NR5A2 ZDHHC14	6.87e-06	176	67	5	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	FBXL7 SGIP1 THSD7A NR5A2 ZDHHC14	6.87e-06	176	67	5	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LMOD3 THBS1 SGIP1 ATRNL1 LTBP1	7.06e-06	177	67	5	b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	FBXL7 THSD7A NR5A2 ZDHHC14 TM4SF18	7.25e-06	178	67	5	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_A\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZNF600 PTPRC KRT81 KRT86 RORA	7.66e-06	180	67	5	023c83f0c9d0280983c6fd28ecf04bfa6b1b89e2
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THBS1 PTPRC PHF3 VPS13C SCAF11	8.52e-06	184	67	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBXL7 SGIP1 NR5A2 ZDHHC14 TM4SF18	9.45e-06	188	67	5	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBXL7 SGIP1 NR5A2 ZDHHC14 TM4SF18	9.45e-06	188	67	5	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PTPRC KRT81 KRT83 KRT86 RORA	9.70e-06	189	67	5	723c57f278919e8251d56b3d19411f9088319450
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	9.70e-06	189	67	5	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PTPRC KRT81 KRT83 KRT86 RORA	9.70e-06	189	67	5	960374f5fb278659500a7c948c3068a95dd62eb0
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRC KRT81 KRT83 KRT86 NR5A2	9.95e-06	190	67	5	ce049630ed69d31f00acbc1b5b0896efc592121f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	9.95e-06	190	67	5	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTPRC KRT81 KRT83 KRT86 RORA	9.95e-06	190	67	5	af39d2a46d9502cec69a69b7e8ffef78fc8311c3
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	FBXL7 THSD7A NR5A2 ZDHHC14 TM4SF18	9.95e-06	190	67	5	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	facs-GAT-Fat-24m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFEMP1 THSD7A LRP1 LTBP1 TMEFF2	9.95e-06	190	67	5	3720e64129f3f3268b1dc14031a76f41c38241c2
ToppCell	facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFEMP1 THSD7A LRP1 LTBP1 TMEFF2	9.95e-06	190	67	5	73a50426f972f08f9bb525ad5c0b774187ab5d6a
ToppCell	facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFEMP1 THSD7A LRP1 LTBP1 TMEFF2	9.95e-06	190	67	5	b55cf1fb586b724295b7b038483249847bb344fc
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	THBS1 FBXL7 SGIP1 RORA LTBP1	9.95e-06	190	67	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	9.95e-06	190	67	5	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	IPF-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	EFEMP1 FBXL7 SGIP1 ZDHHC14 TM4SF18	9.95e-06	190	67	5	ac029e73da5995221c9b9af551d85e4b835e21d6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	1.02e-05	191	67	5	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 SGIP1 ATRNL1 LRP1 LTBP1	1.02e-05	191	67	5	1caf726bd07fdca389e678fc16304a6ef1790423
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFEMP1 THSD7A VPS13C RORA LTBP1	1.02e-05	191	67	5	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	1.02e-05	191	67	5	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	1.02e-05	191	67	5	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THBS1 EFEMP1 MID1 LRP1 TMEFF2	1.02e-05	191	67	5	1b26056df078674f37a6c06f6256b30cfcec21a7
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 SGIP1 ATRNL1 LRP1 LTBP1	1.02e-05	191	67	5	3d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCell	IPF-Endothelial-Lymphatic\|IPF / Disease state, Lineage and Cell class	EFEMP1 FBXL7 SGIP1 ZDHHC14 TM4SF18	1.05e-05	192	67	5	2496edd8f3a41146d418879de9ee2ccc7857431f
ToppCell	COPD-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	EFEMP1 FBXL7 SGIP1 ZDHHC14 TM4SF18	1.07e-05	193	67	5	25bdc557055b5bce6a21f8696b48e991c696b979
ToppCell	Control-Endothelial-Lymphatic\|Control / Disease state, Lineage and Cell class	EFEMP1 FBXL7 NR5A2 ZDHHC14 TM4SF18	1.07e-05	193	67	5	64d19be73e5432d491436a01da5de5c926b615a9
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBXL7 THSD7A NR5A2 ZDHHC14 LTBP1	1.07e-05	193	67	5	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	THBS1 FBXL7 SGIP1 RORA LTBP1	1.10e-05	194	67	5	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 ATRNL1 LRP1 LTBP1	1.10e-05	194	67	5	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 ATRNL1 LRP1 LTBP1	1.10e-05	194	67	5	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 ATRNL1 LRP1 LTBP1	1.13e-05	195	67	5	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FBXL7 SGIP1 ATRNL1 LRP1 LTBP1	1.13e-05	195	67	5	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EFEMP1 FBXL7 ATRNL1 LRP1 LTBP1	1.13e-05	195	67	5	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 ATRNL1 LRP1 LTBP1	1.13e-05	195	67	5	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBXL7 ST8SIA6 NR5A2 ZDHHC14 TM4SF18	1.13e-05	195	67	5	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	distal-Hematologic-Natural_Killer_T-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PTPRC KRT81 KRT83 KRT86 NR5A2	1.16e-05	196	67	5	05d2a15ba702b07ef59c55891a06da02cdd15f7f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 ATRNL1 LRP1 LTBP1	1.16e-05	196	67	5	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 ATRNL1 LRP1 LTBP1	1.16e-05	196	67	5	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	FBXL7 ST8SIA6 NR5A2 ZDHHC14 TM4SF18	1.16e-05	196	67	5	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	distal-Hematologic-Natural_Killer_T\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PTPRC KRT81 KRT83 KRT86 NR5A2	1.19e-05	197	67	5	5cb1b45f5dc8fbd9e54db9c943450ce2cc7000e4
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	THBS1 FBXL7 SGIP1 RORA LTBP1	1.19e-05	197	67	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 EFEMP1 SGIP1 ATRNL1 LTBP1	1.19e-05	197	67	5	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 EFEMP1 SGIP1 ATRNL1 LTBP1	1.19e-05	197	67	5	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	nucseq-Endothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBXL7 ST8SIA6 NR5A2 ZDHHC14 TM4SF18	1.19e-05	197	67	5	ebf9be068eaa658493fa7884fd19f34642922acb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 SGIP1 ATRNL1 LTBP1	1.19e-05	197	67	5	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	THBS1 FBXL7 SGIP1 RORA LTBP1	1.19e-05	197	67	5	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PTPRC PHF3 VPS13C RORA SCAF11	1.21e-05	198	67	5	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 FBXL7 SGIP1 ATRNL1 LTBP1	1.21e-05	198	67	5	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FBXL7 SGIP1 NR5A2 ZDHHC14 TM4SF18	1.21e-05	198	67	5	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	IPF-Stromal\|IPF / Disease state, Lineage and Cell class	EFEMP1 FBXL7 SGIP1 RORA LTBP1	1.21e-05	198	67	5	ece914c32c9b123b779aa9624b92e6230763a20e
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FBXL7 SGIP1 NR5A2 ZDHHC14 TM4SF18	1.21e-05	198	67	5	e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCell	ILEUM-non-inflamed-(6)_ILC-(6)_ILC3\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CERK SGIP1 KRT81 KRT86 RORA	1.24e-05	199	67	5	ba144739f65560207303c0143e8de1e86922bebb
ToppCell	ILEUM-inflamed-(6)_ILC-(6)_ILC3\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CERK SGIP1 KRT81 KRT86 RORA	1.24e-05	199	67	5	02879df850b0c72b57d7b22cfc43f3407e182dcb
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THBS1 FBXL7 SGIP1 LRP1 LTBP1	1.27e-05	200	67	5	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THBS1 FBXL7 SGIP1 LRP1 LTBP1	1.27e-05	200	67	5	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THBS1 FBXL7 SGIP1 LRP1 LTBP1	1.27e-05	200	67	5	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	droplet-Tongue-nan-24m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT39 KRT81 KRT83 KRT86	1.85e-05	104	67	4	a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A ST8SIA6 SHOC1 LRRC9	6.96e-05	146	67	4	e887e9de895fd453faa703997ef372cc6410fc49
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZNF713 KRT81 KRT86 BICRAL	7.53e-05	149	67	4	f18bddc84b064f3d57a1281d5172c404d87f25da
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_E\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZNF600 KRT81 KRT86 BICRAL	9.22e-05	157	67	4	0362c04b7b0b5017964b3a73ee678ae53e7238d7
ToppCell	Severe-Lymphoid-NK-Proliferating_T\|Severe / Condition, Lineage, Cell class and cell subclass	ZNF665 KRT81 KRT86 TG	9.92e-05	160	67	4	cb2276d9bd78508644420e9580d3c17b914224cb
ToppCell	Control-Treg\|World / Disease group and Cell class	LMOD3 SGIP1 SHOC1 SESN3	1.02e-04	161	67	4	ead9f5a491321f9e307f7c97e47a4ca124f59bb6
ToppCell	10x5'-Lung-Lymphocytic_T_CD4/8-lo\|Lung / Manually curated celltypes from each tissue	PTPRC KRT81 KRT86 NR5A2	1.02e-04	161	67	4	a1f10e04836848b1deaf295fae033f54d1572fcd
ToppCell	normal-na-Lymphocytic_T-T4_reg-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PTPRC THSD7A SESN3 RORA	1.07e-04	163	67	4	43887e7687fc6367efac0c1f56a9534b06f47b7f
ToppCell	10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-\|GI_small-bowel / Manually curated celltypes from each tissue	ST8SIA6 KRT81 KRT83 KRT86	1.09e-04	164	67	4	36e64e4f717dd59b352c20ff9742ca1e232342bb
ToppCell	Endothelial-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	SGIP1 THSD7A LYPD3 TM4SF18	1.12e-04	165	67	4	10087d8bd2985906ef19547fe77eb178ae5e1638
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated\|Liver / Manually curated celltypes from each tissue	CCDC66 ZFYVE9 ANKRD26 SESN3	1.14e-04	166	67	4	9afa33b5ad27dc33576be592f9b22d8161366838
ToppCell	NS-critical-d_0-4-Epithelial-unknown_epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FBXL7 HDX SHOC1 BICRAL	1.14e-04	166	67	4	dd02bbe4af609c6348dc92417254f4740f2900a8
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EFEMP1 CENPF GABRQ TG	1.17e-04	167	67	4	a90f905ef38437752e2b0b71bd0322a184de1861
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-ILC3\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SGIP1 KRT81 KRT86 RORA	1.20e-04	168	67	4	4f2f78e14f044b535847bcdbbcec8c0fc8529870
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFEMP1 LRP1 GABRQ TMEFF2	1.22e-04	169	67	4	bb43abad2c049b7f4d307737347290e01b3339a3
ToppCell	facs-Heart-LV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THBS1 EFEMP1 THSD7A RORA	1.22e-04	169	67	4	849a8f8509c58d65462a09c84d58b6ecdc8934f5
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFEMP1 LRP1 GABRQ TMEFF2	1.22e-04	169	67	4	5f18e3f40a5b1b167903f37516ec8181e889c7c5
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFEMP1 LRP1 GABRQ TMEFF2	1.22e-04	169	67	4	8bfa2d3bb541d02f55d7c95b8fd156c8403befca
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTPRC ST8SIA6 KRT81 KRT86	1.28e-04	171	67	4	f16cb64b8844c2668922c786888efaa9f873afcc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 SGIP1 ZNF665 ATRNL1	1.28e-04	171	67	4	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THBS1 SGIP1 ZNF665 ATRNL1	1.28e-04	171	67	4	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	Endothelial-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	EFEMP1 FBXL7 ZDHHC14 TM4SF18	1.31e-04	172	67	4	d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell	Control-Endothelial_cells-Systemic_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	FBXL7 THSD7A NR5A2 TM4SF18	1.31e-04	172	67	4	c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRC CENPF ZNF679 NOD2	1.31e-04	172	67	4	ef33b5e0515c6d29fb6d9a673011c1b68ef264f3
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	ATRNL1 LTBP1 BSN TMEFF2	1.34e-04	173	67	4	75e26a65071b0d2f30ed0b2aa9859c488f5cf362
ToppCell	droplet-Liver-Npc-18m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC MID1 LRP1 ADAM17	1.34e-04	173	67	4	9ba55e21d1037ec3150d77895e52f0b051df65da
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	ATRNL1 LTBP1 BSN TMEFF2	1.34e-04	173	67	4	26e2e674f5d312fa8f61c11b553dc6101f063b16
Drug	Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; HL60; HT_HG-U133A	FBN2 FBXL7 ZFYVE9 TRPC5 ZDHHC14 ADAM17 C8A PML	9.38e-08	198	65	8	3018_DN
Drug	Azathymine, 6 [932-53-6]; Up 200; 31.4uM; HL60; HT_HG-U133A	FBXL7 ZFYVE9 THSD7A ZDHHC14 LRP1 LTBP1 PML	1.49e-06	197	65	7	2466_UP
Drug	tebuquine	KRT81 KRT83	8.03e-06	2	65	2	CID000071991
Drug	3,5-di-O-galloylquinic acid	KRT81 KRT83	8.03e-06	2	65	2	CID000460896
Drug	melicopicine	KRT81 KRT83	8.03e-06	2	65	2	CID000101253
Drug	Pregnenolone [145-13-1]; Up 200; 12.6uM; MCF7; HT_HG-U133A	ZFYVE9 ZNF652 TRPC5 MID1 PRDM2 PML	1.56e-05	187	65	6	2856_UP
Drug	ATBI	KRT81 KRT83 KRT86	1.76e-05	18	65	3	CID000505862
Drug	PF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A	CENPF ANKRD26 ZNF701 ADAM17 AKAP1 PML	1.87e-05	193	65	6	6421_UP
Drug	Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A	THBS1 ZNF652 MID1 NR5A2 PRDM2 PML	1.98e-05	195	65	6	4696_UP
Drug	Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	THBS1 ZFYVE9 CENPF KRT83 NR5A2 ZDHHC14	2.04e-05	196	65	6	3331_UP
Drug	Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A	THBS1 FBXL7 ZFYVE9 ZDHHC14 PRDM2 PML	2.10e-05	197	65	6	3463_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A	XYLT2 CENPF ZNF652 ZDHHC14 LRP1 BICRAL	2.10e-05	197	65	6	6623_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A	XYLT2 ZNF665 ANKRD26 ADAM17 PRDM2 PML	2.10e-05	197	65	6	7342_DN
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	PHF3 ANKRD26 LYPD3 LTBP1 PRDM2 PML	2.10e-05	197	65	6	2117_UP
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; PC3; HT_HG-U133A	EFEMP1 FBXL7 ZNF701 BICRAL ADAM17 PML	2.16e-05	198	65	6	4568_DN
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A	PHF3 ZNF652 ANKRD26 ZNF701 PRDM2 PML	2.16e-05	198	65	6	2256_DN
Drug	sulfonamide-3	KRT81 KRT83	2.40e-05	3	65	2	CID009847197
Drug	AC1L1BIT	KRT81 KRT83 KRT86 GABRQ	2.62e-05	60	65	4	CID000001457
Drug	FAH2	KRT81 KRT83 TRPC5 TG	3.38e-05	64	65	4	CID000000661
Drug	pyriproxyfen	KRT81 KRT83 KRT86	3.78e-05	23	65	3	CID000091753
Drug	Dabcyl	THBS1 ZFYVE9 ADAM17	4.31e-05	24	65	3	CID000022650
Drug	Salmfamide 1	FBN2 TG	4.80e-05	4	65	2	CID005487416
Drug	lactucin	KRT81 KRT83	4.80e-05	4	65	2	CID000442266
Drug	Lactupicrin	KRT81 KRT83	4.80e-05	4	65	2	CID000174880
Drug	Succimer	XYLT2 TET2 CERK THBS1 PTPRC PHF3 TRPC5 MID1 NR5A2 ZDHHC14 LRP1 ANKRD26 PRDM2	4.93e-05	1264	65	13	ctd:D004113
Drug	dictamnine	KRT81 KRT83	1.19e-04	6	65	2	CID000068085
Drug	skimmianine	KRT81 KRT83	1.19e-04	6	65	2	CID000006760
Drug	arborinine	KRT81 KRT83	1.19e-04	6	65	2	CID005281832
Drug	TGQA	KRT81 KRT83	1.67e-04	7	65	2	CID000127406
Drug	4-amino-2-trifluoromethyl-phenyl retinate	BECN1 PML	1.67e-04	7	65	2	ctd:C585745
Drug	Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A	XYLT2 CERK ZDHHC14 AKAP1 PML	1.96e-04	187	65	5	6764_DN
Drug	Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	THBS1 ZFYVE9 ZNF652 PRDM2 NOD2	2.01e-04	188	65	5	2854_UP
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	THBS1 PHF3 ZNF665 ZNF652 LYPD3	2.01e-04	188	65	5	4545_DN
Drug	Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A	CENPF PHF3 ZNF652 PALB2 PML	2.01e-04	188	65	5	2053_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	XYLT2 PHF3 ZNF652 SCAF11 LTBP1	2.17e-04	191	65	5	4283_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	XYLT2 THBS1 PHF3 LTBP1 PML	2.17e-04	191	65	5	6644_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	THBS1 PHF3 LTBP1 ADAM17 PRDM2	2.22e-04	192	65	5	4104_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A	THBS1 PHF3 ZNF652 BICRAL PRDM2	2.22e-04	192	65	5	4274_DN
Drug	Butacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A	XYLT2 ZFYVE9 PHF3 ZNF652 ADAM17	2.22e-04	192	65	5	3469_DN
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HG-U133A	THBS1 EFEMP1 CENPF VPS13C SCAF11	2.22e-04	192	65	5	1929_DN
Drug	tesmilifene	PTPRC LRP1	2.22e-04	8	65	2	ctd:C043062
Drug	desethylchloroquine	KRT81 KRT83	2.22e-04	8	65	2	CID000095478
Drug	Pivampicillin [33817-20-8]; Down 200; 8.6uM; PC3; HT_HG-U133A	THBS1 PHF3 ZNF665 ZNF652 PML	2.27e-04	193	65	5	5046_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	XYLT2 THBS1 PHF3 ANKRD26 LTBP1	2.27e-04	193	65	5	6931_DN
Drug	Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	ZFYVE9 PHF3 AKAP1 PRDM2 PML	2.33e-04	194	65	5	2087_DN
Drug	Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; HL60; HT_HG-U133A	FBXL7 ZFYVE9 PHF3 ZNF652 PML	2.33e-04	194	65	5	1858_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	PHF3 ZDHHC14 BICRAL MBIP PML	2.33e-04	194	65	5	7137_DN
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A	THBS1 FBXL7 NR5A2 PRDM2 PML	2.33e-04	194	65	5	2520_DN
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; HL60; HT_HG-U133A	ZFYVE9 PHF3 ADAM17 AKAP1 PML	2.33e-04	194	65	5	1308_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A	ZFYVE9 ZNF652 ANKRD26 AKAP1 PML	2.33e-04	194	65	5	2893_UP
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	XYLT2 THBS1 EFEMP1 LTBP1 PRDM2	2.38e-04	195	65	5	6971_DN
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A	THBS1 PHF3 VPS13C ADAM17 C8A	2.38e-04	195	65	5	5568_UP
Drug	Cytisine (-) [485-35-8]; Down 200; 21uM; PC3; HT_HG-U133A	FBXL7 CENPF ANKRD26 LYPD3 PML	2.38e-04	195	65	5	5739_DN
Drug	troglitazone; Down 200; 10uM; HL60; HT_HG-U133A	ZFYVE9 ZDHHC14 ANKRD26 BICRAL LTBP1	2.38e-04	195	65	5	6191_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	ZFYVE9 GABRQ RORA C8A TG	2.38e-04	195	65	5	5569_UP
Drug	Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A	FBXL7 ZFYVE9 CENPF PHF3 PML	2.44e-04	196	65	5	2781_UP
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	KRT83 MID1 RORA ZNF701 PML	2.44e-04	196	65	5	3871_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A	ZNF665 SCAF11 BICRAL PRDM2 PML	2.44e-04	196	65	5	2065_DN
Drug	NS-398; Up 200; 10uM; MCF7; HT_HG-U133A	VPS13C NR5A2 RORA ZNF701 PML	2.44e-04	196	65	5	6911_UP
Drug	sulfite	THBS1 EFEMP1 LRP1 SESN3 LRP1B PRDM2 TMEFF2	2.47e-04	438	65	7	CID000001099
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A	THBS1 FBXL7 CENPF GABRQ BICRAL	2.50e-04	197	65	5	4997_UP
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A	XYLT2 PHF3 MID1 ZDHHC14 PML	2.50e-04	197	65	5	4761_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	FBXL7 KRT83 MID1 ANKRD26 PML	2.50e-04	197	65	5	4123_DN
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A	THBS1 ZFYVE9 ANKRD26 RORA ADAM17	2.50e-04	197	65	5	5589_UP
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; HL60; HT_HG-U133A	XYLT2 FBXL7 MID1 ANKRD26 PML	2.50e-04	197	65	5	6138_DN
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A	FBXL7 ZFYVE9 TRPC5 C8A PML	2.50e-04	197	65	5	3004_DN
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	THBS1 CENPF PHF3 ZNF652 PRDM2	2.50e-04	197	65	5	2860_UP
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; HL60; HT_HG-U133A	XYLT2 ZFYVE9 ZDHHC14 ANKRD26 BICRAL	2.50e-04	197	65	5	2934_DN
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A	ZFYVE9 ZNF665 LYPD3 AKAP1 PRDM2	2.50e-04	197	65	5	5867_DN
Drug	Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CENPF NR5A2 ANKRD26 PML NOD2	2.50e-04	197	65	5	6506_UP
Drug	PNU-0293363 [326823-19-2]; Down 200; 10uM; PC3; HT_HG-U133A	XYLT2 ZFYVE9 PHF3 ZNF701 PML	2.56e-04	198	65	5	6568_DN
Drug	Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A	KRT83 ZNF701 ADAM17 PRDM2 PML	2.56e-04	198	65	5	7018_UP
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	THBS1 ZFYVE9 ADAM17 AKAP1 PML	2.56e-04	198	65	5	5595_UP
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; HL60; HT_HG-U133A	XYLT2 FBXL7 PHF3 ZDHHC14 C8A	2.56e-04	198	65	5	3051_DN
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A	CENPF PHF3 ATRNL1 TRPC5 ZNF701	2.56e-04	198	65	5	5611_DN
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A	FBXL7 CENPF PHF3 MID1 PML	2.56e-04	198	65	5	5406_UP
Drug	paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A	XYLT2 ZNF652 ANKRD26 GABRQ PRDM2	2.56e-04	198	65	5	640_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A	PHF3 ZDHHC14 ADAM17 PRDM2 PML	2.56e-04	198	65	5	2246_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	PHF3 LRP1 LYPD3 ADAM17 PRDM2	2.56e-04	198	65	5	3793_DN
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A	THBS1 CENPF ANKRD26 PRDM2 PML	2.56e-04	198	65	5	3581_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	XYLT2 ZFYVE9 PHF3 PRDM2 PML	2.56e-04	198	65	5	2069_DN
Drug	Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	THBS1 FBXL7 TRPC5 PRDM2 PML	2.62e-04	199	65	5	6743_DN
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A	FBXL7 PHF3 RORA TG NOD2	2.62e-04	199	65	5	4362_UP
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A	ZFYVE9 ATRNL1 TRPC5 ZNF701 PML	2.62e-04	199	65	5	5617_DN
Drug	0198306-0000 [212631-61-3]; Up 200; 10uM; MCF7; HT_HG-U133A	CERK ZFYVE9 LTBP1 ADAM17 PML	2.62e-04	199	65	5	7099_UP
Drug	Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	FBN2 ZDHHC14 ANKRD26 LYPD3 PML	2.62e-04	199	65	5	7250_UP
Drug	Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A	THBS1 PTPRC PHF3 LYPD3 PML	2.68e-04	200	65	5	6329_UP
Drug	Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	XYLT2 THBS1 ANKRD26 AKAP1 MBIP	2.68e-04	200	65	5	6484_DN
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A	MID1 ANKRD26 ADAM17 AKAP1 PML	2.68e-04	200	65	5	6005_UP
Drug	Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	FBN2 FBXL7 CENPF RORA AKAP1	2.68e-04	200	65	5	6029_UP
Drug	bisdesethylchloroquine	KRT81 KRT83	2.85e-04	9	65	2	CID000122672
Drug	adipamide	MID1 TG	2.85e-04	9	65	2	CID000012364
Drug	Magnetite Nanoparticles	XYLT2 TET2 CERK THBS1 PTPRC PHF3 MID1 NR5A2 ZDHHC14 LRP1 ANKRD26 PRDM2	2.95e-04	1310	65	12	ctd:D058185
Drug	SFBs	THBS1 LTBP1	3.56e-04	10	65	2	CID000131431
Disease	Beaded hair	KRT81 KRT83 KRT86	1.02e-08	3	65	3	cv:C0546966
Disease	MONILETHRIX	KRT81 KRT83 KRT86	1.02e-08	3	65	3	158000
Disease	monilethrix (is_implicated_in)	KRT81 KRT83 KRT86	1.02e-08	3	65	3	DOID:0050472 (is_implicated_in)
Disease	Monilethrix	KRT81 KRT83 KRT86	4.07e-08	4	65	3	C0546966
Disease	hair disease (is_implicated_in)	KRT81 KRT86	4.78e-06	2	65	2	DOID:421 (is_implicated_in)
Disease	glaucoma	EFEMP1 THSD7A RORA LTBP1 LRP1B	2.33e-05	154	65	5	MONDO_0005041
Disease	Prostatic Neoplasms	TET2 PTPRC CENPF SESN3 LRP1B PALB2 TMEFF2 PML	6.11e-05	616	65	8	C0033578
Disease	Malignant neoplasm of prostate	TET2 PTPRC CENPF SESN3 LRP1B PALB2 TMEFF2 PML	6.11e-05	616	65	8	C0376358
Disease	osteoarthritis	EFEMP1 ATRNL1 LTBP1 AKAP1 PRDM2	1.32e-04	222	65	5	MONDO_0005178
Disease	WNT1-inducible-signaling pathway protein 1 measurement	C8A TG	2.13e-04	10	65	2	EFO_0008321
Disease	adverse effect, response to xenobiotic stimulus	FBXL7 LRP1B TMEFF2	3.04e-04	59	65	3	EFO_0009658, GO_0009410
Disease	age at menarche	TET2 ATRNL1 RORA BSN LRP1B PRDM2 PML	3.28e-04	594	65	7	EFO_0004703
Disease	Migraine Disorders	LRP1 GABRQ	3.67e-04	13	65	2	C0149931
Disease	body weight	TET2 FBN2 EFEMP1 PHF3 VPS13C HDX RORA LTBP1 LRP1B TMEFF2	4.13e-04	1261	65	10	EFO_0004338
Disease	calcium measurement	TET2 FBN2 SHOC1 LYPD3 RORA AKAP1 LRP1B	4.57e-04	628	65	7	EFO_0004838
Disease	epilepsy (implicated_via_orthology)	KCNA1 LRP1 BSN LRP1B	4.67e-04	163	65	4	DOID:1826 (implicated_via_orthology)
Disease	hepatocellular carcinoma (is_marker_for)	TET2 KDM3A EFEMP1 LRP1B PML	5.35e-04	301	65	5	DOID:684 (is_marker_for)
Disease	household income	TET2 SGIP1 THSD7A BSN LRP1B	5.60e-04	304	65	5	EFO_0009695
Disease	uterine prolapse	FBN2 EFEMP1	5.62e-04	16	65	2	EFO_1001864
Disease	serum iron measurement	ZDHHC14 RORA LRP1B	9.16e-04	86	65	3	EFO_0006332
Disease	age of onset of childhood onset asthma	ZNF652 RORA NOD2	1.11e-03	92	65	3	OBA_2001015
Disease	insular cortex volume measurement	THSD7A VPS13C	1.17e-03	23	65	2	EFO_0010309
Disease	diffusing capacity of the lung for carbon monoxide	KRT86 ZDHHC14 LRP1B	1.26e-03	96	65	3	EFO_0009369
Disease	temperament and character inventory	FBN2 TG	1.28e-03	24	65	2	EFO_0004825
Disease	asthma	PTPRC ZNF665 ZNF652 LRP1 RORA LRP1B NOD2	1.30e-03	751	65	7	MONDO_0004979
Disease	Pancreatic Neoplasm	EFEMP1 NR5A2 PALB2	1.42e-03	100	65	3	C0030297
Disease	FEV/FEC ratio	TET2 EFEMP1 VPS13C SLMAP LRP1 LTBP1 MBIP PML TG	1.43e-03	1228	65	9	EFO_0004713
Disease	lean body mass	TET2 EFEMP1 VPS13C LTBP1 PML	1.50e-03	379	65	5	EFO_0004995
Disease	Malignant neoplasm of pancreas	EFEMP1 NR5A2 PALB2	1.50e-03	102	65	3	C0346647
Disease	neuroticism measurement, cognitive function measurement	TET2 THSD7A RORA LRP1B TMEFF2 TG	1.54e-03	566	65	6	EFO_0007660, EFO_0008354
Disease	lower face morphology measurement	RORA LTBP1 LRP1B	1.81e-03	109	65	3	EFO_0010948
Disease	birth weight	TET2 CENPF RORA ADAM17 PML	1.87e-03	399	65	5	EFO_0004344
Disease	Huntington disease, disease progression measurement	ST8SIA6 ATRNL1	2.00e-03	30	65	2	EFO_0008336, MONDO_0007739

Protein segments in the cluster

Peptide	Gene	Start	Entry
CQASQLQGQKEESCV	AKAP1	376	Q92667
VRQAQCGQDFQCKET	C8A	91	P07357
DRKCQLNVCDNENRT	ANKRD26	101	Q9UPS8
TFQDQIECNCLKRNE	LRRC9	1431	Q6ZRR7
ANCTTANQNCVNKSK	KCNA1	476	Q09470
QSKNCFQLILQCAQE	HDX	26	Q7Z353
KCVCDQNFQERNNTC	LRP1B	3866	Q9NZR2
QQVVTSSQQQQCCQK	KRT39	296	Q6A163
KAKEQIRNCENNCQQ	LMOD3	176	Q0VAK6
IRNCENNCQQVTDKA	LMOD3	181	Q0VAK6
NLFNCKNCANEAVVQ	GABRQ	46	Q9UN88
EAQFECQNHRCISKQ	LRP1	2736	Q07954
NNSKRRCKVNCETDQ	LINC02872	106	A2RU37
TKLQFYQNRECCQSN	KRT86	136	O43790
NFNTCTQCHNKVCNQ	BSN	186	Q9UPA5
QLNVTENECQNYKRC	BECN1	151	Q14457
NTFCQDINECQLQGV	LTBP1	621	Q14766
QQCAQDRCNAKLNLT	LYPD3	106	O95274
FTFKENQLCRNTCQE	PALB2	816	Q86YC2
SCKNAQLARDFQQCS	FAM189B	116	P81408
VDNESCCSRSNNKIQ	KDM3A	491	Q9Y4C1
TQQQFFCQAQKKCLN	BICRAL	606	Q6AI39
CRAEQAFQASQIKEN	CENPF	461	P49454
ANCFDLQTLNVQDCE	FBXL7	451	Q9UJT9
CFVCRQSKQQLEEEQ	CERK	351	Q8TCT0
EKENNRCNDQCNQFT	CCDC66	671	A2RUB6
RCNDQCNQFTRIEKQ	CCDC66	676	A2RUB6
TCINNNVCEQCKNLT	ATRNL1	1021	Q5VV63
ENNVREFCNVIDCNQ	MBIP	176	Q9NS73
CQTKQHNCQFLCVNT	FBN2	2536	P35556
NQSANCLKSCNEQIE	SCAF11	441	Q99590
TKLQFYQNRECCQSN	KRT83	141	P78385
VQETFNKNFVCNVCE	PRDM2	1126	Q13029
NNKRYTCIENQNCQI	NR5A2	116	O00482
TCIENQNCQIDKTQR	NR5A2	121	O00482
NECDASNQCAQQCYN	EFEMP1	256	Q12805
QAERPNNQQNCFKVC	THSD7A	101	Q9UPZ6
QNECYLRQAACKQQS	TMEFF2	111	Q9UIK5
EFQFLRCQQCQAEAK	PML	51	P29590
CLEKCSALQNQNQDL	SHOC1	71	Q5VXU9
SCCDAVQNFVVSQNN	ST8SIA6	131	P61647
AQECFQERSNKVCGN	ADAM17	466	P78536
CNQCGKVFTQNSNLA	ZNF665	656	Q9H7R5
NCEECDNTFNQSSNL	ZNF431	541	Q8TF32
CVGDVTENQICNKQD	THBS1	531	P07996
CEMCSQEAFQAQRSQ	NOD2	26	Q9HC29
ENNNNYKCCQSENCS	TM4SF18	71	Q96CE8
QQSNATYSCPRQKNC	RORA	101	P35398
LCCDNTQNDANTKEF	SGIP1	631	Q9BQI5
NFCVCDLANDNNIEN	SESN3	231	P58005
SFQLRCQQCEDQQRE	SLMAP	636	Q14BN4
CNEVNQCLSTTQNKI	ZNF679	141	Q8IYX0
AQQIANCKQCIERSA	MID1	296	O15344
CNECGKVFSQNSNLQ	ZNF534	481	Q76KX8
LCSAEKNSCVQQSDN	PHF3	1701	Q92576
NAFCVIVCNEKNNIA	VPS13C	1091	Q709C8
NAFNVFVCDQKCNIA	VPS13C	1606	Q709C8
TATNQQNKRNQCSCN	ROS1	1316	P08922
QNKRNQCSCNVTEFE	ROS1	1321	P08922
QSQSDMCDQDQCIQS	ZDHHC14	351	Q8IZN3
ECNQVEKSFNNNSSV	ZNF347	206	Q96SE7
QDNQEECFKQVIRTC	ZNF790	131	Q6PG37
NNCKGIRCEKQNNAF	TRPC5	551	Q9UL62
QERSLECNKFAENCN	ZNF713	176	Q8N859
ECNKFAENCNLNSNL	ZNF713	181	Q8N859
CNECGKVFNQQSNLA	ZNF701	366	Q9NV72
QQTDCEKNIQCVSCN	ZNF652	291	Q9Y2D9
CNECDKAFNQQSNLA	ZNF600	276	Q6ZNG1
KCNECGKAFNQQSQL	ZNF600	611	Q6ZNG1
RCFQEQEQKSQQASV	TET2	881	Q6N021
KLNVNENVECGNNTC	PTPRC	251	P08575
QCAEDGSFQTVQCQN	TG	51	P01266
ASTKQCQQEIANVVC	XYLT2	176	Q9H1B5
NCDKRTLQNDLQDCN	ZFYVE9	156	O95405
QDSQECCRQAVQGRQ	nan	76	Q6ZVH6
TKLQFYQNRECCQSN	KRT81	136	Q14533